EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
ROME and MILAN, Jan. 14, 2025 /PRNewswire/ — Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics.
"AI in clinical and molecular diagnostics uses artificial intelligence to analyze medical data, such as lab tests and genetic information, more quickly and accurately. BCC Research Highlights ...